Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3,062 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Association of ulcerative colitis symptom severity and proctocolectomy with multidimensional patient-reported outcomes: a cross-sectional study.
Matsuoka K, Yamazaki H, Nagahori M, Kobayashi T, Omori T, Mikami Y, Fujii T, Shinzaki S, Saruta M, Matsuura M, Yamamoto T, Motoya S, Hibi T, Watanabe M, Fernandez J, Fukuhara S, Hisamatsu T. Matsuoka K, et al. Among authors: yamazaki h. J Gastroenterol. 2023 Aug;58(8):751-765. doi: 10.1007/s00535-023-02005-7. Epub 2023 Jun 23. J Gastroenterol. 2023. PMID: 37351647 Free PMC article.
White Blood Cell Counts and Future Relapse in Ulcerative Colitis under Low-Dose Thiopurine Treatment in Real-World Practice: A 3-Year Japanese Multi-Center Retrospective Cohort Study.
Kiyohara H, Yamazaki H, Moriya K, Akimoto N, Kawai S, Takenaka K, Fukuda T, Tominaga K, Umeno J, Shinzaki S, Honzawa Y, Takagi T, Ichikawa H, Endo T, Ozaki R, Andoh A, Matsuoka K, Hibi T, Kobayashi T; IBD Terakoya Group. Kiyohara H, et al. Among authors: yamazaki h. Inflamm Intest Dis. 2023 Dec 28;9(1):1-10. doi: 10.1159/000535889. eCollection 2024 Jan-Dec. Inflamm Intest Dis. 2023. PMID: 38298887 Free PMC article.
Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing.
Fukuda T, Yamazaki H, Miyatani Y, Sawada T, Shibuya N, Fukuo Y, Kiyohara H, Morikubo H, Tominaga K, Kakimoto K, Imai T, Yaguchi K, Yamamoto S, Ando K, Nishimata N, Yoshihara T, Andoh A, Hibi T, Matsuoka K; IBD Terakoya Group. Fukuda T, et al. Among authors: yamazaki h. Aliment Pharmacol Ther. 2024 Apr 23. doi: 10.1111/apt.18013. Online ahead of print. Aliment Pharmacol Ther. 2024. PMID: 38651779
Anti-integrin αvβ6 autoantibodies in patients with primary sclerosing cholangitis.
Yoshida H, Shiokawa M, Kuwada T, Muramoto Y, Ota S, Nishikawa Y, Maeda H, Kakiuchi N, Okamoto K, Yamazaki H, Yokode M, Nakamura T, Matsumoto S, Hirano T, Okada H, Marui S, Sogabe Y, Matsumori T, Mima A, Uza N, Eso Y, Takai A, Takahashi K, Ueda Y, Kodama Y, Chiba T, Seno H. Yoshida H, et al. Among authors: yamazaki h. J Gastroenterol. 2023 Aug;58(8):778-789. doi: 10.1007/s00535-023-02006-6. Epub 2023 Jun 13. J Gastroenterol. 2023. PMID: 37310456 Free PMC article.
Anti-integrin αvβ6 autoantibodies are a potential biomarker for ulcerative colitis-like immune checkpoint inhibitor-induced colitis.
Yokode M, Shiokawa M, Kawakami H, Kuwada T, Nishikawa Y, Muramoto Y, Kitamoto H, Okabe M, Yamazaki H, Okamoto N, Morita T, Ohno K, Nakanishi R, Takimoto I, Yasuda M, Chikugo K, Matsumoto S, Yoshida H, Ota S, Nakamura T, Okada H, Hirano T, Kakiuchi N, Matsumori T, Yamamoto S, Uza N, Ooi M, Kodama Y, Chiba T, Hayashi H, Seno H. Yokode M, et al. Among authors: yamazaki h. Br J Cancer. 2024 May;130(9):1552-1560. doi: 10.1038/s41416-024-02647-1. Epub 2024 Mar 9. Br J Cancer. 2024. PMID: 38461170 Free PMC article.
3,062 results